Biomaterial Database

Fundamental carcinogenic processes and their implications for low dose risk assessment. 1976

K S Crump, and D G Hoel, and C H Langley, and R Peto

Various possible models of carcinogenesis are analyzed with respect to low dose kinetics. The importance of background carcinogenesis upon the shape of the dose-response curve at low dose is emphasized. It is shown that, if carcinogenesis by an external agent acts additively with any already ongoing process, then under almost any model the response will be linear at low dose. Measures of the degree of linearity are obtained for multistage models of carcinogenesis, where it is shown that throughout the dose range where the extra risk is less than the spontaneous risk linear extrapolation must be quite accurate.

UI	MeSH Term	Description	Entries
D008433	Mathematics	The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)	Mathematic
D008954	Models, Biological	Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.	Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009369	Neoplasms	New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002274	Carcinogens, Environmental	Carcinogenic substances that are found in the environment.	Environmental Carcinogens
D004305	Dose-Response Relationship, Drug	The relationship between the dose of an administered drug and the response of the organism to the drug.	Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D012306	Risk	The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome.	Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor

Related Publications

K S Crump, and D G Hoel, and C H Langley, and R Peto

Fundamental carcinogenic processes and their implications for low-dose risk assessment.

June 1978, Cancer research,

K S Crump, and D G Hoel, and C H Langley, and R Peto

An improved procedure for low-dose carcinogenic risk assessment from animal data.

July 1984, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,

K S Crump, and D G Hoel, and C H Langley, and R Peto

Non-linear biological responses to formaldehyde and their implications for carcinogenic risk assessment.

August 1983, Carcinogenesis,

K S Crump, and D G Hoel, and C H Langley, and R Peto

Analyses of carcinogenesis dose-response relations with dichotomous data: implications for carcinogenic risk assessment.

January 1982, Teratogenesis, carcinogenesis, and mutagenesis,

K S Crump, and D G Hoel, and C H Langley, and R Peto

Carcinogenic risk assessment: are there dose thresholds for carcinogens?

January 2010, Asian Pacific journal of cancer prevention : APJCP,

K S Crump, and D G Hoel, and C H Langley, and R Peto

Low dose mixture effects of endocrine disrupters and their implications for regulatory thresholds in chemical risk assessment.

December 2014, Current opinion in pharmacology,